Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
0.9% saline solution, eye drops is an isotonic, physiological ophthalmic solution of sodium chloride. In the context of clinical trials, such as the Phase III trial (NCT07050446) sponsored by Jadran Galenski laboratorij (JGL), it is utilized as a placebo comparator to evaluate the efficacy and safety of investigational eye drops (such as Vizol S DIGI EYE) in patients with moderate to severe evaporative dry eye disease. As an inert vehicle, it lacks a specific pharmacological biological target and serves primarily to maintain blinding and provide a baseline control during clinical investigations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride (7e75e8).